Home

P SHERRILL NEFF

CIK 1189158 · last filed 2026-03-06

P SHERRILL NEFF is a corporate insider who has filed 35 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ACR, was dated Mar 6, 2026. Across all open-market trades the lifetime net is +$9.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $561.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$561.5K

Companies

6

Total Filings

35

Lifetime Open-Market Net

$9.10M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACR Director 31,006 $18.11 $561.5K $0 13 2026-03-06
MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted Director 2,529,642 — — $8.99M 8 2016-10-07
Tobira Therapeutics, Inc. (TBRA) Delisted Director — — — $0 1 2015-01-06
Tobira Therapeutics, Inc. (RGDO) Delisted Director 143,780 — — $287.2K 2 2014-01-03
ACRES Commercial Realty Corp. (RSO) Delisted Director 6,939 — — -$181.1K 7 2012-03-14
AMICUS THERAPEUTICS, INC. (FOLD) Delisted Director 1,419,762 $14.49 $20.57M $0 4 2010-06-17

Recent Filings

35 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-06 ACR Grant (A) +5,555 $0 EDGAR
2024-05-08 ACR Grant (A) +4,762 $0 EDGAR
2022-05-09 ACR Grant (A) +4,762 $0 EDGAR
2021-05-21 ACR Grant (A) +6,666 $0 EDGAR
2020-03-10 ACR Grant (A) +3,944 $0 EDGAR
2019-03-12 ACR Grant (A) +3,762 $0 EDGAR
2018-03-09 ACR Grant (A) +4,347 $0 EDGAR
2017-03-09 ACR Grant (A) +4,920 $0 EDGAR
2016-10-07 MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted Other (J) −997,512 $0 EDGAR
2016-03-09 ACR Grant (A) +3,710 $0 EDGAR
Showing 1–10 of 35
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.